Rrs Pharma & Surgical Twin Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.14 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Rrs Pharma & Surgical Twin
Rrs Pharma & Surgical Twin Private Limited (RPSTPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2011 and has a history of 13 years and 11 months. Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.14 M, as per Ministry of Corporate Affairs (MCA) records.
Rajni Bansal, Sanjay Bansal, Ranju Bansal, and One other member serve as directors at the Company.
Company Details
-
Location
Faridabad, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232HR2011PTC042208
-
Company No.
042208
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2011
-
Date of AGM
14 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rrs Pharma & Surgical Twin?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajni Bansal
|
Director | 24-Feb-2011 | Current |
|
Sanjay Bansal
|
Director | 24-Feb-2011 | Current |
|
Ranju Bansal
|
Director | 24-Feb-2011 | Current |
|
Anju Mehra
|
Director | 01-Oct-2012 | Current |
Financial Performance of Rrs Pharma & Surgical Twin.
Rrs Pharma & Surgical Twin Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rrs Pharma & Surgical Twin?
In 2017, Rrs Pharma & Surgical Twin had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Spark Metfab Private LimitedRajni Bansal is a mutual person
-
Aventure Pharma Private Limited
Rajni Bansal, Sanjay Bansal and 1 more are mutual person
-
Krenko Technologies Private Limited
Rajni Bansal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rrs Pharma & Surgical Twin?
Unlock and access historical data on people associated with Rrs Pharma & Surgical Twin, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rrs Pharma & Surgical Twin, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rrs Pharma & Surgical Twin's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
